Kronox Lab Sciences Ltd
NSE: KRONOX BSE: 544187
Incorporated in 2008, Kronox Lab Sciences Ltd manufactures High Purity Fine, inorganic chemicals, phosphate, and metallic chemicals[1]
₹129
52W: ₹96 — ₹207
PE 18.5 · Book ₹27.3 · +373% vs bookMarket Cap₹479 Cr
Stock P/E18.5Price to Earnings
ROCE43.8%Return on Capital
ROE32.6%Return on Equity
Div. Yield0.41%Face Value ₹10
Strengths
- +Company is almost debt free.
- +Company has delivered good profit growth of 24.3% CAGR over last 5 years
- +Company has a good return on equity (ROE) track record: 3 Years ROE 35.9%
Shareholding Pattern
Promoters74.21%
FIIs0.08%
DIIs2.05%
Public23.66%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% | 74.21% |
| FIIs | 1.56% | 0.56%▼1.0 | 0.49%▼0.1 | 0.05%▼0.4 | 0.03%▼0.0 | 0.03% | 0.05%▲0.0 | 0.08%▲0.0 |
| DIIs | 4.34% | 2.57%▼1.8 | 2.2%▼0.4 | 2.2% | 1.71%▼0.5 | 1.93%▲0.2 | 2%▲0.1 | 2.05%▲0.0 |
| Public | 19.89% | 22.66%▲2.8 | 23.1%▲0.4 | 23.54%▲0.4 | 24.04%▲0.5 | 23.84%▼0.2 | 23.74%▼0.1 | 23.66%▼0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.02 | 20.71 | 22.18 | 25.19 | 24.86 | 24.01 | 26.13 | 24.29 | 25.53 | 25.27 |
| Expenses | 15.16 | 14.63 | 14.33 | 16.98 | 16.06 | 15.65 | 18.38 | 16.32 | 16.88 | 17.24 |
| Operating Profit | 5.86 | 6.08 | 7.85 | 8.21 | 8.8 | 8.36 | 7.75 | 7.97 | 8.65 | 8.03 |
| OPM % | 27.88% | 29.36% | 35.39% | 32.59% | 35.4% | 34.82% | 29.66% | 32.81% | 33.88% | 31.78% |
| Net Profit | 4.35 | 4.74 | 5.88 | 6.15 | 6.47 | 6.53 | 6.32 | 6.28 | 6.68 | 6.59 |
| EPS ₹ | 1.17 | 1.28 | 1.58 | 1.66 | 1.74 | 1.76 | 1.7 | 1.69 | 1.8 | 1.78 |
AI Insights
Revenue Trend
TTM revenue at ₹101Cr, up 1% YoY. OPM at 32%.
Debt Position
Borrowings at ₹3Cr. Debt-to-equity ratio: 0.05x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1Cr (3% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 2.05% (-2.29pp change). FIIs: 0.08% (-1.48pp change). Promoters hold 74.21%.
Margin & Efficiency
ROCE improving from 0% (Mar 2020) to 44% (Mar 2025). Working capital days: 168.
Valuation
PE 18.5x with 43.8% ROCE. Price is 373% above book value of ₹27.3. Dividend yield: 0.41%.
Recent Announcements
- Board Meeting Intimation for Consider And Approve Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Final Dividend 2d - Board meets May 20, 2026 to approve FY26 audited results and consider dividend.
- Clarification On Price Movement 8 Apr - Kronox Lab Sciences clarifies share price movement is market-driven and no undisclosed information exists.
- Clarification sought from Kronox Lab Sciences Ltd 8 Apr - Exchange has sought clarification from Kronox Lab Sciences Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that …
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 3 Apr - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.
- Closure of Trading Window 26 Mar
- Financial Year 2025 from bse
- Financial Year 2024 from bse